3 completed, 3 not yet recruiting, 2 recruiting, 1 active not recruiting. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 3, Not yet recruiting 3, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Overweight , Obesity: new trials by email Literature Review of Overweight , Obesity trials Research Report on Overweight , Obesity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of UBT37034 Injection UBT37034, Placebo - Overweight , Obesity | Phase 1 | Not yet recruiting | The United Bio-Technology (Hengqin) Co., Ltd. | 40 | 2026-10-01 | 2026-10-14 |
| Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants MWN110, Placebo - Overweight , Obesity | Phase 1 | Not yet recruiting | Shanghai Minwei Biotechnology Co., Ltd | 103 | 2026-08-26 | 2026-08-24 |
| A Study of SRSD384 in Overweight or Obese Participants SRSD384 injection, Placebo - Overweight , Obesity | Phase 1 / Phase 2 | Not yet recruiting | Sirius Therapeutics Co., Ltd. | 78 | 2026-06-01 | 2026-06-05 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults IBIO-600, Placebo - Overweight , Obesity | Phase 1 | Recruiting | iBio, Inc. | 32 | 2026-05-24 | 2026-05-29 |
| A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese Participants MWN109 Tablets - Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity | Phase 1 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 162 | 2026-05-24 | 2026-09-03 |
| Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity MWN105 1, MWN105 2, MWN105 3 - Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Recruiting | Shanghai Minwei Biotechnology Co., Ltd | 36 | 2026-04-26 | 2026-09-08 |
| A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants Zovaglutide - Overweight , Obesity | Phase 1 | Active not recruiting | Beijing QL Biopharmaceutical Co.,Ltd | 40 | 2026-04-13 | 2026-10-21 |
| Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 1 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 40 | 2025-07-14 | 2026-10-28 |
| Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers MWN105, Placebo - Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 55 | 2024-12-19 | 2026-09-03 |
Obesity (9) · Overweight (9) · Diabetes Mellitus, Type 2 (3)
Body Weight (9) · Nutrition Disorders (9) · Nutritional and Metabolic Diseases (9) · Overnutrition (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3)
Shanghai Minwei Biotechnology Co., Ltd (5) · Beijing QL Biopharmaceutical Co.,Ltd (1) · Sirius Therapeutics Co., Ltd. (1) · The United Bio-Technology (Hengqin) Co., Ltd. (1) · iBio, Inc. (1)
China (6) · Australia (2)
Cory Schwartz, PhD (1) · Wei Zhao, PhD (1)